ArthroCare CE marks WoundWand
This article was originally published in Clinica
Executive Summary
ArthroCare has CE marked its WoundWand debridement device for sale in Europe. The device removes dead or damaged tissue from a wound in a "precise and controlled manner", Austin, Texas-based ArthroCare says. Debridement is carried out in wounds that have not properly healed on their own, as the dead tissue can lead to infections and abscesses, as well as delaying healing further. The device employs the firm's Coblation technology, which uses low-temperature radiofrequency energy to dissolve rather than burn soft tissue, minimising damage to healthy tissue. WoundWand is not yet approved by the US FDA.